Sacubitril 24 MG / valsartan 26 MG Oral Tablet — RxCUI 1656340
RxNorm drug concept · Semantic clinical drug
RxCUI 1656340
Semantic clinical drug · SCD
● Current RxNorm concept 88 FDA products
211 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1656340
Official nameSacubitril 24 MG / valsartan 26 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped88
Package NDCs mapped211
Reported Medicaid activity (SDUD)784,473 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Valsartan and Sacubitril: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sacubitril and valsartan works on two fronts at once. One part (sacubitril) helps your body's own protective heart hormones stick around longer, which helps your kidneys get rid of...
- What exactly is this medication supposed to do for my heart failure?
- That's a really important question. A few combinations need to be avoided or watched carefully. You should never take this with an ACE inhibitor like lisinopril or enalapril at the...
- Can I take it with my other medications? I'm also on ibuprofen sometimes for pain.
🕸️ Concept Web — How Sacubitril 24 MG / valsartan 26 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sacubitril 24 MG / valsartan 26 MG Oral Tablet
RxCUI 1656340 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Sacubitril
1656328IN -
Valsartan
69749IN -
Sacubitril / valsartan
1656339MIN
-
Sacubitril
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Entresto
1656341BN
-
Entresto
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sacubitril / valsartan Oral Tablet
1656338SCDF -
Sacubitril / valsartan Oral Product
1656336SCDG -
Sacubitril / valsartan Pill
1656337SCDG -
Sacubitril / valsartan Oral Tablet [Entresto]
1656343SBDF -
Entresto Oral Product
1656344SBDG -
Entresto Pill
1656345SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Sacubitril / valsartan Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sacubitril 24 MG
1656334SCDC -
Valsartan 26 MG
1656335SCDC -
Sacubitril 24 MG / valsartan 26 MG Oral Tablet [Entresto]
1656346SBD -
Sacubitril 24 MG / valsartan 26 MG [Entresto]
1656342SBDC
-
Sacubitril 24 MG
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sacubitril 24 MG
SCDC · 1656334 -
Valsartan 26 MG
SCDC · 1656335 -
Sacubitril / valsartan Oral Tablet
SCDF · 1656338 -
Sacubitril / valsartan Oral Product
SCDG · 1656336 -
Sacubitril / valsartan Pill
SCDG · 1656337
Brand-Name Concepts
-
Sacubitril 24 MG / valsartan 26 MG Oral Tablet [Entresto]
SBD · 1656346 -
Sacubitril 24 MG / valsartan 26 MG [Entresto]
SBDC · 1656342 -
Sacubitril / valsartan Oral Tablet [Entresto]
SBDF · 1656343 -
Entresto Oral Product
SBDG · 1656344 -
Entresto Pill
SBDG · 1656345 -
Entresto
BN · 1656341
📦 FDA Products & Package NDCs
88 products · 211 package NDCs
211 package NDCs map to RxCUI 1656340 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 73190-0019-18 | 180 TABLET, FILM COATED in 1 BOTTLE (73190-019-18) | Sacubitril and Valsartan | AvKARE | 2025-11-16 |
| 73190-0019-60 | 60 TABLET, FILM COATED in 1 BOTTLE (73190-019-60) | Sacubitril and Valsartan | AvKARE | 2025-11-16 |
| 82293-0027-10 | 60 TABLET, FILM COATED in 1 BOTTLE (82293-027-10) | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
| 82293-0027-20 | 180 TABLET, FILM COATED in 1 BOTTLE (82293-027-20) | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
| 82293-0027-30 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (82293-027-30) / 10 TA... | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
| 82293-0028-10 | 60 TABLET, FILM COATED in 1 BOTTLE (82293-028-10) | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
| 82293-0028-20 | 180 TABLET, FILM COATED in 1 BOTTLE (82293-028-20) | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
| 82293-0028-30 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (82293-028-30) / 10 TA... | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
| 82293-0029-10 | 60 TABLET, FILM COATED in 1 BOTTLE (82293-029-10) | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
| 82293-0029-20 | 180 TABLET, FILM COATED in 1 BOTTLE (82293-029-20) | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
| 82293-0029-30 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (82293-029-30) / 10 TA... | Sacubitril and Valsartan | Novugen Pharma (USA) LLC | 2025-07-16 |
Observed labelers:
Torrent Pharmaceuticals Limited (20) ·
AvKARE (15) ·
Laurus Labs Limited (15) ·
Alembic Pharmaceuticals Inc. (12) ·
Alembic Pharmaceuticals Limited (12) ·
Biocon Pharma Inc. (12)
· +21 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.